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Pregnancy-Associated Plasma
rotein-A Is Markedly Expressed
y Monocyte-Macrophage Cells in Vulnerable
nd Ruptured Carotid Atherosclerotic Plaques
Link Between Inflammation and Cerebrovascular Events
iuseppe Sangiorgi, MD, FESC,* Alessandro Mauriello, MD,‡ Elena Bonanno, MD,‡ Claus Oxvig, PHD,¶
heryl A. Conover, MD,§ Michael Christiansen, MD,# Santi Trimarchi, MD,† Vincenzo Rampoldi, MD,†
avid R. Holmes, JR, MD, FACC, Robert. S. Schwartz, MD, FACC,** Luigi Giusto Spagnoli, MD‡
ilan and Rome, Italy; Rochester, Minnesota; Aarhus and Copenhagen, Denmark; and Minneapolis, Minnesota
OBJECTIVES The study aim was to evaluate serologic expression of pregnancy-associated protein-A
(PAPP-A) in patients affected by cerebrovascular accidents and to correlate it with
histopathologic carotid plaque complexity.
BACKGROUND Little is known about PAPP-A expression in carotid atherosclerotic disease and whether this
protein represents a marker of plaque vulnerability also in carotid district.
METHODS Seventy-two carotid plaques from patients submitted to surgical endarterectomy (19 who suffered
a major stroke, 24 transient ischemic attack, and 29 asymptomatic) were evaluated. Serologic
PAPP-A levels were determined by enzyme-linked immunoadsorbent assay. Plaques were divided
in three groups based on histology: 1) stable (n  38); 2) vulnerable (n  13); 3) ruptured with
thrombus (n  14). Immunohistochemical staining for PAPP-A, smooth muscle cells,
macrophages, and T-lymphocytes was performed in all cases. Real-time polymerase chain
reaction assessed local PAPP-A production, and double immunofluorescence confocal
microscopy (ICM) characterized cell type expressing PAPP-A.
RESULTS Pregnancy-associated protein-A (serologic values were 4.02  0.18 mIU/l in Group 1, 7.43 
0.97 mIU/l in Group 2, and 6.97 0.75 mIU/l in Group 3 [1 vs. 3, p 0.01; 1 vs. 2, p 0.004;
2 vs. 3, p  0.71, respectively]). Pregnancy-associated protein-A (expression showed a mean
score value of 0.62  0.06 for stable plaques, 2.54  0.14 for vulnerable plaques, and 2.71 
0.12 for ruptured plaques [1 vs. 2, p  0.001; 1 vs. 3, p  0.001; 2 vs. 3, p  0.37,
respectively]). Real-time polymerase chain reaction demonstrated local messenger ribonucleic
acid PAPP-A production, and double ICM confirmed monocyte/macrophage expression of
PAPP-A in Groups 2 and 3 but not Group 1.
CONCLUSIONS This study suggests that PAPP-A is a marker of carotid plaque destabilization and rupture.
Further studies are necessary to determine if PAPP-A can represents a new target for
stratifying the risk of cerebrovascular events. (J Am Coll Cardiol 2006;47:2201–11) © 2006
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.086by the American College of Cardiology Foundation
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scentral role for inflammation in the pathogenesis of
therosclerosis has been demonstrated by multiple his-
opathologic, experimental, and clinical studies (1–9). How-
ver, the challenge of recognizing vulnerable plaque nonin-
asively at early stages, and before the onset of an acute
linical event, still remains.
Carotid plaque disruption and distal embolization of
theromatous plaque debris is the most common pathogenic
echanism for cerebral ischemia from carotid atheroscle-
otic disease. Our group and other investigators have shown
hat histomorphologic composition of the atherosclerotic
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nstitute, Copenhagen, Denmark; and the **Department of Cardiovascular Disease,
inneapolis Heart Foundation, Minneapolis, Minnesota.t
Manuscript received August 22, 2005; revised manuscript received September 27,
005, accepted November 1, 2005.laque, rather than the degree of stenosis, is a major
eterminant for increased risk of plaque rupture and subse-
uent thrombosis in the carotid territory (10–12).
It is thus clear that the clinical debate should move from
hether to treat to whom to treat. Recently, several biolog-
cal markers have been proposed to identify unstable,
ulnerable plaques, including high-sensitivity C-reactive
rotein (hsCRP), serum matrix metalloproteinases
MMPs), and soluble adhesion molecules. Elevated levels of
sCRP were shown to be predictive of coronary or periph-
ral atherosclerosis and to constitute an independent pre-
ictor of advanced carotid plaques in hyperlipidemic subjects
13). Several MMPs are overexpressed in atherosclerotic le-
ions by inflammatory cells, therefore playing a role in the
rogression and destabilization of the disease (14–16). Re-
ently, pregnancy-associated plasma protein-A (PAPP-A), a
ovel, high-molecular, zinc-binding metalloproteinase de-
cribed during pregnancy, is highly expressed in both rup-
ured and eroded coronary unstable plaques from patients
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PAPP-A and Vulnerable Carotid Plaque June 6, 2006:2201–11ho died suddenly from cardiac causes (17). Pregnancy-
ssociated plasma protein-A has been found to be an
ndependent predictor for the presence and extent of coro-
ary artery disease in stable patients (18) and cardiovascular
vents in high-risk patients affected by acute coronary
yndromes (19). Moreover, Beaudeux et al. (20) found that
levated serum PAPP-A levels are associated not only with
he echogenicity of atherosclerotic carotid lesions but also
ith an enhanced inflammatory state in asymptomatic
yperlipidemic subjects.
However, little is known about PAPP-A cellular expres-
ion in carotid atherosclerotic disease and if this protein
ould be a marker of vulnerability in the carotid artery
istribution. The aim of this study was to evaluate PAPP-A
xpression in stable and unstable carotid atherosclerotic
laques collected from patients undergoing surgical carotid
ndarterectomy.
ETHODS
ase selection. Seventy-two carotid atherosclerotic plaques
rom patients undergoing carotid endarterectomy at Mayo
linic and Foundation, Rochester, Minnesota (25 patients)
nd at San Donato Hospital, San Donato Milanese, Italy
47 patients) formed the study population. Nineteen plaques
ere obtained from patients who suffered a nonlacunar
troke, 24 from patients who suffered transient ischemic
ttack (TIA), and 29 plaques from asymptomatic patients.
A routine preoperative evaluation in all patients included
linical assessment of risk factor profile, a cerebral computed
omographic (CT) scan study, a Duplex examination, and a
elective angiographic examination of extracranial and in-
racranical carotid arteries and their branches.
Major stroke was defined as a clinical syndrome charac-
erized by rapidly developing focal or at times global
ymptoms without significant clinical improvement within
even days in the distribution of symptomatic carotid artery,
ot hemorrhagic, and with no cause other than vascular
rigin, assessed by brain CT study as a cortical or deep white
atter or basal ganglia lesion bigger than 1 cm. Transient
schemic attack was defined as recent (120 days before
urgery) occurrence of any sudden focal neurological deficit
Abbreviations and Acronyms
CT  computed tomography
FITC  streptavidin-fluorescin conjugate
hsCRP  high-sensitivity C-reactive protein
ICM  immunofluorescence confocal microscopy
MMPs  serum matrix metalloproteinases
NASCET  North American Symptomatic Carotid
Endarterectomy Trial
PAPP-A  pregnancy-associated protein-A
RT-PCR  quantitative real-time polymerase chain
reaction
TIA  transient ischemic attackhat cleared completely within 24 h (12). Asymptomatic patients had never suffered from neurological symptoms and
ad no cerebral lesions assessed by CT.
Patients were excluded from the study if: 1) they had a
robable cardiac embolus source (rhythm disorders, mitral
alve stenosis, prolapse or calcification, mechanical cardiac
alves, recent myocardial infarction, left ventricular throm-
us, atrial myxoma, endocarditis, dilated cardiomyopathy,
atent foramen ovale); or 2) symptoms that could be
ttributed to nonatherosclerotic disease (aneurysm, fibro-
uscular dysplasia); or 3) stenosis 50% of the circle of
illis.
Angiographic carotid stenosis was measured utilizing the
ethod from the North American Symptomatic Carotid
ndarterectomy Trial (NASCET) (21) by two independent
hysicians; intraobserver and interobserver reliability was
ore than 98%. The time interval range between symptom
nset and carotid endarterectomy was from 3 to 22 months
or patients with stroke/TIA and 4 to 21 months for
symptomatic patients.
The study was approved by both institutional review
oards, and all patients gave verbal consent to the study.
lasma protein assay of PAPP-A. Blood samples were
btained in fasting individuals by venipuncture the day
efore the surgical procedure, placed on ice, and centrifuged
ithin 30 min at 1,600  g for 5 min. All samples were
nalyzed by personnel who had no knowledge of the
ubjects’ clinical data (C.O.); PAPP-A levels were deter-
ined by means of a biotin-tyramide-amplified enzyme
mmunoassay with a limit of detection of 0.03 mIU/l and
ntra-assay and inter-assay coefficients of variation of 10%
nd 15%, respectively. Pregnancy-associated protein-A
olyclonal antibodies were used for capture (22), and a
ombination of monoclonal antibodies was used for detec-
ion (23) as previously described. The assay was calibrated
gainst the World Health Organization’s international refer-
nce standard 78/610, which is the standard for pregnancy-
ssociated proteins.
istologic sampling and light microscopy. Carotid
laques were removed en bloc during surgery to preserve
laque structure entirely. Sixty-five of those plaques were
tilized for histologic examination, and six plaques for
ibonucleic acid molecular assay. For histology, surgical
amples were fixed for 24 h in 10% buffered formalin
mmediately upon removal, a method previously described
y our group (12). After decalcification, specimens were
ectioned transversely every 5 mm and paraffin embedded.
ematoxylin-eosin and Movat pentachrome stains were
erformed for morphologic study. Each segment was se-
uentially numbered to reconstruct the entire plaque length.
or each plaque, 3 to 10 sections were examined according
o the plaque length (mean, 5 sections per specimen).
Plaques were evaluated for acute thrombosis associated
ith plaque rupture, minimum cap thickness, and cross-
ectional area of lipid-necrotic core. The latter was calcu-
ated manually, tracing the perimeter of the different com-
onents of the vessel. Plaque rupture was defined as
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June 6, 2006:2201–11 PAPP-A and Vulnerable Carotid Plaqueomplete disruption of a fibrous cap over a lipid core, with
cute thrombus in contact with the lipid pool. Thrombus
as defined as platelets or fibrin on the plaque surface, and
haracterized by lamination with or without red and white
ells interspersed (24).
mmunohistochemistry. To characterize plaque’s cell
opulation and PAPP-A expression, single-label immu-
ohistochemistry was performed. Five micron sections
ere deparaffinized, and endogenous peroxidase activity
as blocked with H2O2. Primary antibodies (anti-human
D3, dilution 1:100, Dako, Glostrup, Denmark; anti-
uman neutrophil CD15, dilution 1:100, Dako; anti-
uman CD68, dilution 1:100, Dako; anti-human PAPP-A
dvanced, clone 234-5 [23], dilution 1:100, anti–alpha-
mooth muscle actin, dilution 1:100, Sigma, St. Louis,
issouri) were applied for 1 h at room temperature fol-
owed by a secondary antibody incubation (biotinylated goat
nti-mouse, dilution 1:40 or goat anti-rabbit, dilution 1:20)
or 30 min at room temperature. Then, avidin biotin
mplification (ABC kit) was applied for 30 min at room
emperature. Incubation with 0.1% 3=,3=-diaminobenzidine
nd H2O2 at room temperature for 5 to 10 min produced a
rown reaction pigment. A light hematoxylin counterstain-
ng was used to visualize all nuclei in the tissue sections.
ontrol sections were incubated with a mixture of irrelevant
onoclonal reagents with a similar isotype.
Two pathologists (A.M. and E.B.) blinded to the clinical
ndings evaluated all histocytologic components of the
laques. Intra- and interobserver variability was95%. Cell
ounting was performed at magnification of 40 using a
est grid with an area of 0.22 mm2. An average of 10 fields
er section or a number of microscopic fields until the SEM
as less than 5% were counted. The PAPP-A positivity was
emiquantitatively scored as maximal (3), moderate (2),
ow (1), very low (0.5), or absent (0).
istologic definitions and atherosclerotic plaque types.
laques were classified according to the modified American
eart Association atherosclerosis classification (25) and to
he recent consensus document of the American Heart
ssociation (26) into three categories: ruptured plaques,
haracterized by the presence of an acute thrombus associated
ith plaque rupture; and vulnerable plaques, including thin
brous cap atheromata, characterized by a lesion composed of
lipid-rich core covered by a 65 m-thick fibrous cap
ontaining many lipid-laden macrophage foam cells (25 per
igh-power magnification) (25). The remaining plaques were
lassified as stable plaques.
Based on histologic characteristics, carotid plaques were
hus divided into three groups (Table 1): Group 1 comprised
8 stable atherosclerotic plaques (5 of whom showed organized
hrombosis) and were considered as control group, Group 2
omprised 13 “vulnerable but not ruptured plaques”, and
roup 3 comprised 14 “ruptured plaques” showing cap rupture
nd thrombosis at the histologic examination .
onfocal immunohistochemistry microscopy. To char-
cterize the cells’ subpopulations expressing PAPP-A, dou- lle immunostaining for confocal microscopy was performed
n selected cases. Briefly, 5-m paraffin sections of carotid
laques were first incubated with monoclonal antibodies to
APP-A (clone 234-5, dilution 1:100, 1 h at room tem-
erature), rinsed and then incubated with biotinilated
ouse IgG, then rinsed again and incubated with antibodies
onjugated to streptavidin peroxidase. Fluorescence was
btained by incubating the sections with a streptavidin-
uorescin conjugate (FITC). After this first reaction, a
econd reaction with primary antibodies respectively to
MA, CD68, CD3 (dilution 1:100, 1 h at room tempera-
ure in the dark) was performed as described above, and
uorescence was obtained with a streptavidin-Texas Red
uorescent conjugate. Control sections were incubated with
mixture of irrelevant monoclonal reagents with a similar
sotype. Specimens were observed under an Olympus fluo-
escence microscope. Images were acquired by means of
oran confocal microscope at 60X/1.4 NA immersion oil
ens. Three-dimensional stacks were acquired at resolution
f 0.1 m in X, Y, Z axis.
uantitative real-time polymerase chain reaction (RT-
CR) assay. To demonstrate local production of PAPP-A
ithin the carotid tissue, a RT-PCR assay was performed on
even carotid plaques (one from asymptomatic patient, four
rom TIA, and two from stroke) by personnel who had no
nowledge of the subjects’ clinical data (C.A.C). Briefly, after
emoval from the patient of the carotid plaque, a tissue ring was
mmediately obtained by cutting the central segment of the
natomic tissue sample, submerged in plastic vials containing 3
c of RNA later ribonucleic acid stabilization reagent
Quiagen, Valencia, California) and immediately stored at
20C°. Total ribonucleic acid was extracted from plaques
sing the RNeasy Mini Kit (Qiagen) and treated with
eoxyribonuclease (DNA-free, Ambion, Inc., Austin,
exas). Four hundred nanograms of ribonucleic acid were
eversed transcribed using TaqMan RT reagents (PE Bio-
ystems, Foster City, California) according to the manufac-
urer’s instructions. Quantitative real-time polymerase chain
eaction analyses were performed using the ABI PRISM
700 Sequence Detection System and software (PE Applied
iosystems, Foster City, California). Primer and probe
equences for specific detection and amplification of
APP-A and 28S have been described previously (27).
elative messenger ribonucleic acid abundance was calcu-
able 1. Clinical Presentation and Plaque Histologic Types
bserved in the 65 Carotid Plaques Submitted to Histologic
xamination
Histologic
Definition
Stroke
(17 Plaques)
TIA
(20 Plaques)
Asymptomatic
(28 Plaques)
uptured plaques 7 (41.2%) 4 (20.0%) 3 (10.7%)
ulnerable plaques 5 (29.4%) 4 (20.0%) 4 (14.3%)
table plaques 5 (29.4%)* 12 (60.0%) 21 (75.0%)
All five stable plaques corresponded to plaques with organized thrombosis.
TIA  transient ischemic attack.ated using the 2T
C method (28).
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PAPP-A and Vulnerable Carotid Plaque June 6, 2006:2201–11tatistical analysis. Statistical analysis of the data was
erformed using SPSS for Windows (version 11.0, SPSS
nc., Chicago, Illinois). Categorical variables were described
n frequencies. Unpaired t test and one-way analysis of
ariance was utilized to assess intergroup differences for
ontinuous variables. The chi-square test was used to
stablish associations among categorical variables. Correla-
ion coefficients describing the relationship between
APP-A positivity, cap thickness, and plaque inflammation
ere also calculated. A value of p  0.05 was considered as
tatistically significant in all analysis.
ESULTS
linical data. No differences were found between clinical
ariables and risk factor profiles among of the three study
roups (Table 2). Patients who suffered a stroke showed
mean percentage angiographic stenosis of the ipsilateral
nternal carotid artery of 80.7  10.5%, TIA patients of
0.3  6.2%, and asymptomatic patients of 80.6  8.0%
p  NS). Mean percentage contralateral angiographic
tenosis was similar in the three study groups (64.3 
2.4% for stroke vs. 64.4  25.9% for TIA vs. 51.5 
3.0% for asymptomatic; p  NS).
laque morphology. All plaques examined contained a
arge lipid-necrotic core with cholesterol clefts, sometimes
ssociated with widespread calcification, covered by a fi-
rous cap. Plaque cellular composition was quite variable
ut consisted principally of smooth muscle cells and inflam-
atory cells. These cells, macrophage-foam cells (CD68-
ositive cells), and T-lymphocytes (CD3-positive) were
ound in variable amounts around the lipid-necrotic core
shoulder of the plaque) and in the fibrous cap. No neutro-
hils cells were observed within the plaque at the histologic
xamination.
Table 2. Clinical Characteristics of the Study P
Clinical Variables
Asymptom
(29 Patien
Age 69.7  6.
Male gender 21 (72.4%
Angiographic stenosis
Ipsilateral carotid 80.6  8.
Controlateral carotid 51.5  23
Hypertension 19 (65.5%
Diabetes
Type I 2 (6.9%
Type II 4 (13.8%
Cigarette smoking 3 (10.3%
Hypercholesterolemia 19 (65.5%
Hypertrygliceridemia 9 (31.0%
Obesity 1 (3.4%
History of coronary artery diseases
Stable angina 3 (10.3%
Unstable angina 0
Medication with statins 12 (41.4%Values are mean  SD or n (%).
TIA  transient ischemic attack.In Group 1 (stable plaques) five plaques with an orga-
ized thrombus were characterized by fibrous tissue, some-
imes stratified, associated with typical angiomatosis, with a
etwork of large, thin-walled vascular channels and a
ariable number of macrophage cells loaded with hemosid-
rin, visible as scattered brown refractive pigments. These
laques were obtained from patients with lacunar stroke
perated at least 18 months after symptoms onset. “Vulnera-
le” and “ruptured” plaques (Groups 2 and 3) were character-
zed by a thinner cap and a higher inflammatory infiltrate,
rincipally monocytes/macrophages (CD68-positive) and T
ymphocytes (CD3-positive), both in the cap and in shoulder,
s compared with stable plaques (Group 1).
A highly significant difference was present in the inflam-
atory cell infiltrate (CD3 and CD68) between stable and
oth ruptured and vulnerable plaques (19.1  1.3 cell/mm2
n Group 1; 47.0  5.6 cell/mm2 in Group 2; 54.7  2.5
ell/mm2 in Group 3; Group 1 vs. Group 2 p  0.001;
roup 1 vs. Group 3, p  0.001; respectively). Conversely,
o significant differences were observed in the amount of
nflammatory cell infiltrates between Group 2 and Group 3
p  0.23).
mmunohistochemical and confocal localization of
APP-A. Single immunostaining PAPP-A antibody
howed a diffuse positive reaction both in Group 2 “vulner-
ble plaque” and Group 3 “ruptured plaque.” In both groups
here was a strong and diffuse reaction for PAPP-A, mainly
n the foam cells of the cap and shoulder region of the
laque. Conversely, in Groups 1 and 2 the reaction was faint
nd focal.
Semiquantitative analysis of PAPP-A localization
howed a mean score value of 0.62 0.06 for stable plaques,
.54  0.14 for vulnerable plaques, and 2.71  0.12 for
uptured plaques (Group 1 vs. Group 2, p  0.001; Group
lation
TIA
(24 Patients)
Stroke
(19 Patients) p Value
69.8  6.7 66.7  9.3 0.31
19 (72.9%) 14 (73.7%) 0.84
80.3  6.2 80.7  10.5 0.99
64.4  25.9 64.3  22.4 0.30
10 (83.3) 16 (84.2%) 0.20
1 (4.2%) 0
3 (12.5%) 6 (31.6%) 0.37
6 (25.0%) 6 (31.6%) 0.17
15 (62.5%) 16 (84.2%) 0.26
10 (41.7%) 11 (57.9%) 0.18
3 (12.5%) 4 (21.1%) 0.16
5 (20.8%) 1 (5.3%)
1 (4.2%) 1 (5.3%) 0.40
9 (37.5%) 10 (52.6%) 0.59opu
atics
ts)
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June 6, 2006:2201–11 PAPP-A and Vulnerable Carotid Plaquevs. Group 3, p  0.001; Group 2 vs. Group 3, p  0.37,
espectively).
A significative inverse correlation between cap thickness
nd PAPP-A score was observed in plaque samples (r 
.62, p  0.01) (Fig. 1A), whereas positive correlation was
resent between plaque inflammation and PAPP-A score
r  0.70, p  0.01) (Fig. 1B), suggesting that both
igure 1. Graphs showing linear regression between pregnancy-associated p
otal cells’ plaque cap inflammatory infiltrate (B) for the 65 carotid atherosclero
hickness and an increase in inflammatory infiltrate in the cap region of the plaulnerable and ruptured plaques are characterized by high
APP-A expression.
Double immunostaining for confocal microscopy confirmed
trong and diffuse expression of PAPP-A in carotid plaques
rom Groups 2 and 3 (Figs. 2D to 2L). Double immunostain-
ng showed that almost all monocyte/macrophages, both in the
ap and in shoulder of the plaque, strongly expressed PAPP-A.
-A (PAPP-A) score versus plaque thickness (A) and PAPP-A score versusrotein
tic plaques submitted to histopathologic examination. A decrease in cap
que are both strongly correlated with increase in PAPP-A expression.
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PAPP-A and Vulnerable Carotid Plaque June 6, 2006:2201–11igure 2. Photomicrographs of a carotid atherosclerotic plaque removed by carotid endarterectomy from a patients who suffered a major stroke. A vulnerable
laque characterized by a large lipidic-necrotic core, a thin fibrous cap (A, Movat pentachrome, 4) associated to a heavy inflammatory infiltrate constituted
ainly by macrofagic foam cells, CD68-positive (B, 10). A strong positive reaction for pregnancy-associated protein-A was observed (C, 20). (D, 10
nd G, 20) show CD68 antibody revealed by streptavidin-Texas Red fluorescent conjugate. (E, 10 and H, 20) Show pregnancy-associated protein-A
eaction revealed by streptavidin-fluorescin conjugate. Two dimension confocal analysis of the two fluorochromes (F and I) clearly showed a strong and
iffuse positive reaction for pregnancy-associated protein-A in macrophagic cells (concordant double positivity appears as a yellow stain). (K) Shows confocal
nalysis of the two fluorochromes, smooth muscle actin immunostain (red) and pregnancy-associated protein-A stain (green). Smooth muscle cells observed
n this plaque gave rise to a strong positive reaction for pregnancy-associated protein-A (yellow stain). (L) Shows confocal analysis of the two
uorochromes, CD3 immunostain (red) and pregnancy-associated protein-A stain (green). Almost all T lymphocytes (red) observed were negative for
regnancy-associated protein-A in plaques where a diffuse positive reaction was observed (green). Only occasional T lymphocytes were pregnancy-
ssociated protein-A-positive (double positivity, yellow stain, arrow).
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June 6, 2006:2201–11 PAPP-A and Vulnerable Carotid Plaqueoreover, in the same plaques, PAPP-Awas less expressed by
mooth muscle cells, whereas T-lymphocytes (CD3-
ositive) did not co-localize with PAPP-A. Stable plaques
nd plaques with organized thrombosis showed focal
APP-A expression co-localizing only with few monocytes/
acrophages and smooth muscle cells expressing PAPP-A
Figs. 3D to 3H).
APP-A plasma assessment. Patients with vulnerable and
uptured plaques (Groups 2 and 3) showed significant
reater plasmatic expression of PAPP-A compared with
atients with stable plaques (Group 1). In particular,
APP-A plasma values were 4.02  0.18 mIU/l in Group
, 7.43  0.97 mIU/l in Group 2, and 6.97  0.75 mIU/l
n Group 3 (Group 1 vs. Group 3, p  0.01; Group 1 vs.
roup 2, p  0.004; Group 2 vs. Group 3, p  0.71,
espectively). Pregnancy-associated protein-A plasma levels
ignificantly correlated with PAPP-A score (r  0.35, p 
.035), suggesting that circulating levels of this biomarker
eflect its expression within the plaque.
T-PCR assay. Quantitative real-time polymerase chain
eaction demonstrated local messenger ribonucleic acid
xpression in carotid plaques from symptomatic patients
two affected by stroke and four affected by TIA) relative to
plaque from an asymptomatic patient (Fig. 4). All samples
howed detectable PAPP-A messenger ribonucleic acid
ith two of the plaques from patients affected by stroke
emonstrating PAPP-A messenger ribonucleic acid levels
wo- to four-fold greater than control.
ISCUSSION
he present study shows for the first time a clear association
etween PAPP-A, carotid plaque morphology, and related
omplications. First, PAPP-A was highly expressed in
omplicated and vulnerable carotid plaques (i.e., with cap
upture or with a thin fibrous plaque associated with a high
nflammatory infiltrate) and was mainly found in both
onocyte/macrophage cells present in the cap and shoulder
egion of the plaque. Second, carotid plaques classified as
table showed little inflammatory cell infiltration and
APP-A expression in a small percentage of monocyte/
acrophage cells. Third, blood analysis demonstrated that
APP-A levels are elevated in the plasma of patients
earing vulnerable/rupture carotid plaques compared with
table plaques. Therefore, the study strongly suggests that
APP-A is a specific marker of carotid plaque vulnerability
nd that the clinical evaluation of this marker may be of
xtreme help in identifying not only “the plaque” at risk but,
oreover, “the patient” at risk of developing an acute
erebrovascular event.
Clinical trials aimed to demonstrate a benefit of surgical
arotid endarterectomy in reducing the risk of cerebrovas-
ular events have focused on carotid stenosis severity as
ajor risk factor for cerebrovascular events. The results ofhe NASCET study (21), the European Carotid Surgery nrial (ECST) (29), and the Asymptomatic Carotid Ath-
rosclerotic Study (ACAS) (30) suggest that the benefit of
urgery is higher in the presence of severe carotid stenosis
nd that the aggregate risk over five years for ipsilateral
troke and any perioperative stroke is around 11% for
symptomatic patients treated medically. In general, it has
een demonstrated that asymptomatic severe carotid steno-
is carries a low stroke risk rate (31,32). Therefore, these
ata demonstrate that stenosis grade is not sufficient to
dentify patients at high risk of acute cerebrovascular events,
nd other risk factors are of greater importance.
While it is likely that some strokes associated with carotid
rtery disease result from hypoperfusion (33), the majority
f such strokes appear to result from embolization from a
omplicated atherosclerotic plaque or acute occlusion of the
arotid artery with propagation of thrombus in the distal
erebral vascular bed. Different histopathologic studies have
valuated the morphological aspects of carotid plaques
emoved from symptomatic and asymptomatic patients to
ocus on mechanisms underlying plaque destabilization
11,34–37). These studies showed that plaque rupture or
lceration is more common in symptomatic patients, but
umen thrombus and intraplaque hemorrhage is not (38).
oreover, the fibrous cap of symptomatic plaques is thinner
ith greater inflammation, especially macrophage and T
ymphocytes (38–40). In this setting, we have demonstrated
hat patients affected by hyperfibrinogenemia were at in-
reased risk of carotid thrombosis and plaque rupture related
o a greater inflammatory infiltrate and thinner atheroscle-
otic plaque cap compared with patients with lower fibrin-
gen levels, independently from other risk factors (24).
inally, high levels of MMPs have been demonstrated at the
ite of inflammatory infiltrate in the fibrous cap (41).
ecause plaque rupture depends on a balance between the
ensile strength of the plaque and stress exerted on it,
upture is likely triggered by a sudden increase in stress on
he plaque or a sudden reduction in plaque strength. While
he former may be caused by sudden increase in blood
ressure or pulse rate, the latter may be caused by increased
ollagen breakdown due to MMPs release at the fibrous cap
ite. In this setting, increased expression of PAPP-A may
nduce an increase in MMPs due to macrophage chemio-
axis activation and tumor necrosis factor-alpha release (42).
At present, sophisticated imaging techniques such as
ixel density analysis and elastography at Duplex examina-
ion (43,44), magnetic resonance imaging tissue character-
zation (45), or local temperature probes (46,47) all hold
romise for identifying vulnerable plaques and detecting
ilent atheroma noninvasively. In addition, inflammatory
irculating markers such as hsCRP, and adhesion molecules
uch as intercellular adhesion molecule-1 and vascular
ellular adhesion molecule-1 have been correlated with high
ensity of inflammatory cells in the cap and are potential
andidates for vulnerable plaque detection (48–52).
Bayes-Genis et al. (17) demonstrated that PAPP-A, a
ovel zinc-binding MMP that stimulates insulin-like
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PAPP-A and Vulnerable Carotid Plaque June 6, 2006:2201–11igure 3. Photomicrographs of a stable carotid atherosclerotic plaque removed by carotid endarterectomy from an asymptomatic patient. In the shoulder
f the plaque (A, Movat pentachrome, 4), there is a moderate inflammatory infiltrate, constituted mainly by macrophagic foam cells, CD68-positive (B, a
ontiguous section of A). The expression of pregnancy-associated protein-A is very low (C, contiguous section of A). Only few cells are
regnancy-associated protein-A-positive (inset). (D) (20) Shows CD68 antibody revealed by streptavidin-Texas Red fluorescent conjugate. (E) (20)
regnancy-associated protein-A reaction revealed by streptavidin-fluorescin conjugate. Two dimension confocal analysis of the two fluorochromes reported
n F shows that monocytes/macrophages resident in this “stable” plaque were almost negative for pregnancy-associated protein-A. The pregnancy-associated
rotein-A reaction showed only slight and focal positivity. Smooth muscle cells were almost negative for pregnancy-associated protein-A. The
regnancy-associated protein-A reaction showed only slight and focal positivity (G, concordant double positivity appears as a yellow stain, arrow, 10).
H) T lymphocytes and pregnancy-associated protein-A double immunostain (10). Few T lymphocytes (CD3 antibody revealed by streptavidin-Texas
ed fluorescent conjugate) were observed in this plaque, and the reaction for pregnancy-associated protein-A was negative (pregnancy-associated protein-A
evealed by streptavidin-fluorescin conjugate).
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June 6, 2006:2201–11 PAPP-A and Vulnerable Carotid Plaquerowth factor-1 and acts as a pro-atherosclerotic molecule
romoting cell growth responses (42), was associated with
cute coronary syndromes in patients affected by coronary
rtery disease. These authors found that serum levels of
irculating PAPP-A were increased in patients with unsta-
le angina and myocardial infarction. At histopathologic
xamination, PAPP-A was also highly expressed in coro-
ary vulnerable plaques but was only minimally expressed in
table plaques. Moreover, the same study demonstrated that
-reactive protein levels were elevated in 50% of patients
ith acute coronary syndromes, whereas PAPP-A levels
ere significantly high in 85% of patients with unstable
ngina and in 94% of patients with myocardial infarction.
hus, these authors suggested that C-reactive protein is
erhaps a sensitive marker of low-grade, diffuse vascular
nflammation, whereas PAPP-A seems to be a valuable
arker for detecting unstable coronary disease even when
he levels of C-reactive protein are not elevated. Pregnancy-
ssociated protein-A plasma levels have been recently dem-
nstrated to correlate with the presence and extent of
oronary artery disease in patients affected by stable chronic
ngina (18). Moreover, an elegant study done by Heeschen
t al. (19) demonstrated that PAPP-A reliably identifies
igh-risk patients affected by coronary artery disease and is
strong independent predictor of cardiovascular events. On
he carotid district, Beaudeux et al. (20) demonstrated that
n asymptomatic dyslipidemic subjects, elevated serum levels
f PAPP-A were associated with more hyperechoic or
soechoic atherosclerotic carotid lesions and with an en-
anced inflammatory state compared with patients with
ypoechoic lesions, as well as normolipidemic controls.
The present study confirms and extends these previous
bservations, giving histopathologic rationale to the identi-
cation of PAPP-A as a potential marker of vulnerable
arotid atherosclerotic lesions. Our results indicate that
APP-A is expressed in vulnerable and ruptured carotid
igure 4. Bar graphs showing pregnancy-associated protein-A (PAPP-A)
essenger ribonucleic acid (mRNA) expression in carotid plaques collected
y surgical carotid endarterectomy from symptomatic patients relative to
laque from an asymptomatic patient. All samples had detectable PAPP-A
RNA from one- to four-fold greater than control. All data represent
eans of three samples from at least three separately performed experi-
ents. Data are presented as means  SD. S  stroke; T  transient
schemic attack.laques but not in stable ones. Moreover, the production ofAPP-A by activated cells and its release into the extracel-
ular matrix appear to be strongly linked to the local
nflammatory process occurring within the carotid plaque.
n this setting, serologic analysis demonstrating that circu-
ating PAPP-A levels are associated with vulnerable and
uptured lesions may help in identify high-risk lesion/
atient subsets before the onset of clinical symptoms. In
ddition, the present study demonstrates by RT-PCR a
ocal production of PAPP-A within the carotid plaque and
ot a merely absorption of this marker from the blood. All
ymptomatic plaques showed increased PAPP-A produc-
ion compared with control plaques, and interplaque vari-
bility existed between different samples. This suggests the
ypothesis that the latter may be due to different inflam-
atory cell infiltration related, in turn, to different biolog-
cal activity. In addition, it can not be excluded that a
ifferent time interval between symptom onset and surgical
laque removal may also have influenced the amount of
APP-A expression.
onclusions. The present study indicates that PAPP-A is
xpressed in symptomatic patients bearing complex carotid
laques characterized by increased inflammatory cell infil-
ration compared with stable plaques from asymptomatic
ubjects. It is likely that pharmacologic or mechanical
reatments aimed both to decrease the inflammatory infil-
ration occurring in high-risk lesions and stabilize the
therosclerotic plaque will reduce the risk of subsequent
erebrovascular events. Although clinical assessment is fun-
amental to estimate stroke risk, the future use of PAPP-A
s a marker of vulnerable carotid atherosclerotic plaque may
elp in identifying patients at higher risk among those with
arotid stenosis. In this setting, an early determination of
hich plaque carries a higher risk of rapid destabilization by
he means of a biochemical marker detection would con-
ribute to improving the quality of management of ischemic
troke. Furthermore, future studies are necessary to establish
f carotid plaque stabilization by the means of mechanical
ntervention may be also coupled with a reduction in
ulnerable markers expression.
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